Add BrightSurf on Google Email

Science News for February 22, 2005


Cancer in patients with hepatitis C

Researchers found significantly higher risks of non-Hodgkin's lymphoma and multiple myeloma among HCV patients in Sweden. The risk increases with the duration of HCV infection, suggesting that long-lasting infection may contribute to cancer development.

SourceWiley·JournalHepatology·DateFeb 22, 2005

Anti-rollover device for tractors

A team of researchers designed a protective structure to reduce tractor rollover accidents, resulting in improved agricultural worker safety. The 'Estrema' programme calculates necessary structures for various types of tractors, with enhanced models approved for use in the agricultural sector.

Investigational transplant drug effectively preserves kidneys while avoiding toxic side effects

A new investigational transplant drug called LEA29Y has been shown to selectively block the co-stimulatory signal that triggers an immune response, thereby preventing organ rejection and preserving kidney function. This approach avoids the toxic side effects associated with current immunosuppressant medications like cyclosporine.

SourceEmory University Health Sciences Center·JournalAmerican Journal of Transplantation·DateFeb 22, 2005

Research advances quest for HIV-1 vaccine

A study led by Drs. Dennis R. Burton and Ian A. Wilson identified the specific amino acids on gp41 that 4E10 interacts with, revealing its unique ability to target a conserved region near the surface of the virus. This research advances the quest for an HIV-1 vaccine, providing valuable insights into broadly neutralizing antibodies.

SourceCell Press·JournalImmunity·DateFeb 22, 2005